共 237 条
[41]
Stroiakovski D(2017)Systemic therapy for previously untreated advanced BRAF-mutated melanoma: a systematic review and network meta-analysis of randomized clinical trials JAMA Oncol 3 366-e381
[42]
Cipriani A(2015)Pembrolizumab versus Ipilimumab in Advanced Melanoma N Engl J Med 372 2521-1246
[43]
Higgins JP(2013)Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol 14 e60-253
[44]
Geddes JR(2014)Systemic treatment for BRAF-mutant melanoma: where do we go next? Lancet Oncol 15 e371-3060
[45]
Salanti G(2011)Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma J Clin Oncol 29 1239-undefined
[46]
Salanti G(2015)PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials Pigment Cell Melanoma Res 28 245-undefined
[47]
Jansen JP(2015)Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites Clin Cancer Res 21 3052-undefined
[48]
Crawford B(undefined)undefined undefined undefined undefined-undefined
[49]
Bergman G(undefined)undefined undefined undefined undefined-undefined
[50]
Stam W(undefined)undefined undefined undefined undefined-undefined